Regulatory timeline

Approved FDA submissions across all GLP-1 applications, newest first, from Drugs@FDA: original approvals, efficacy supplements and labeling changes. Labeling supplements are where new safety language and new indications actually land, and they are published months before most coverage notices them.

European authorisations

The same molecules as authorised by the European Medicines Agency, from the public register of medicines. A drug approved in one jurisdiction is often not approved in the other, and the indication wording frequently differs — both are worth checking before assuming a US approval carries over.